ASD Acronym,Designation,Title of Standard,Abstract,Link,
MDCG,MDCG 20250129,SARS-CoV-2 on request from the Medical Device Coordination Group (29 January 2025),"Visit the link for more information",https://health.ec.europa.eu/latest-updates/advice-sars-cov-2-request-medical-device-coordination-group-29-january-2025-2025-01-29_en,
MDCG,MDCG 2025-1,EMDN Ad hoc procedure form,"Visit the link for more information",https://health.ec.europa.eu/document/download/e2cb674e-73cb-4a2b-b0d3-76c70505b632_en?filename=mdcg_2025-1_en.docx,
MDCG,MDCG 2024-16,Manufacturer Information Form on Interruption or Discontinuation of Supply of certain medical devices and certain in vitro diagnostic medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/919061d9-5dfa-4d0b-ab9b-3543eed98f76_en?filename=md_mdc-2024-16_en.pdf,
MDCG,MDCG 2024-16 Annex,Device Identification Table,"Visit the link for more information",https://health.ec.europa.eu/document/download/b4a7dea7-ae73-4e13-a8a8-11dcd2678d38_en?filename=md_mdc-2024-16_annex_en.pdf,
MDCG,MDCG 2024-15,Guidance on the publication of the clinical investigation reports and their summaries in the absence of EUDAMED,"Visit the link for more information",https://health.ec.europa.eu/document/download/0e076d19-62dc-4ff9-83f2-be6072a45993_en?filename=mdcg_2024-15_en.pdf,
MDCG,2023/C 163/06,Commission Guidance on the content and structure of the summary of the clinical investigation report,"Visit the link for more information",https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52023XC0508(01),
MDCG,CAMD FAQ,CAMD MDR/IVDR Transition Subgroup: FAQ – MDR Transitional provisions,"Visit the link for more information",https://health.ec.europa.eu/document/download/c294046e-b9e5-428a-a837-3620a5a1c27a_en?filename=md_mdcg_camd_mdr_en.pdf,
MDCG,Conformity assessment procedures for 3D printing and 3D printed products to be used in a medical context for COVID-19,Apr-20,"Visit the link for more information",https://health.ec.europa.eu/document/download/000cf966-c81e-41d7-a452-1b2d4ce17230_en?filename=md_mdcg_qa_3d_ppp_covid-19_en.pdf,
MDCG,Conformity assessment procedures for protective equipment,Jul-20,"Visit the link for more information",https://health.ec.europa.eu/document/download/967ff76e-6e80-4f20-8e6b-02c1d6637aee_en?filename=md_mdcg_qa_conformity_assessment_en.pdf,
MDCG,COVID-19 TESTS: Q&A on in vitro diagnostic medical device conformity assessment and performance in the context of COVID-19,Feb-21,"Visit the link for more information",https://health.ec.europa.eu/document/download/2a160ac0-5041-44a6-b596-a1abf30fc576_en?filename=covid-19_ivd-qa_en.pdf,
EU,EU Commission,Gradual roll out of EUDAMED - Q&As on practical aspects related to the implementation of Regulation (EU) 2024/1860 (November 2024),"Q&A on practical aspects related to the implementation of the gradual roll-out of Eudamed pursuant to the MDR and IVDR, as amended by Regulation (EU) 2024/1860  amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices",https://health.ec.europa.eu/document/download/0e7327c7-0e06-4fbd-90d3-8ab7bb30fe9f_en?filename=md_mdcg_2024-11_eudamed-qa.pdf,
EU,EU Commission,Q&A Obligation to inform in case of interruption or discontinuation of supply,"Q&A Obligation to inform in case of interruption or discontinuation of supply Article 10a of the MDR/IVDR, effective from January 10, 2025, mandates manufacturers to inform about anticipated interruptions or discontinuations of certain medical devices and in vitro diagnostic devices Scope and Responsibility: The obligation applies to all manufacturers, whether inside or outside the EU, and covers devices that could cause serious harm if their supply is interrupted2. Notification Process: Manufacturers must notify economic operators, health institutions, and competent authorities at least six months in advance, unless exceptional circumstances prevent this. Assessment Criteria: Manufacturers must assess and specify reasons for supply interruptions or discontinuations, considering potential serious harm to patients or public health.",https://health.ec.europa.eu/document/download/b431b10f-8512-4f47-9191-e1b84b2f9a27_en?filename=mdr_qna-article10a_mdr-ivdr_en.pdf,
MDCG,European Medicines Agency (EMA) Guidance,"Questions & Answers for applicants, marketing authorisation holders of medicinal products and notified bodies with respect to the implementation of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations ((EU) 2017/745 and (EU) 2017/746)","Visit the link for more information",https://www.ema.europa.eu/en/human-regulatory/overview/medical-devices,
MDCG,"Guidance on medical devices, active implantable medical devices and in vitro diagnostic medical devices in the COVID-19 context",Apr-20,"Visit the link for more information",https://health.ec.europa.eu/document/download/fec7a235-cf90-486f-8c31-9eb00942817c_en?filename=md_mdcg_guidance_md_qa_covid-19_en.pdf,
MDCG,Guidance on regulatory requirements for medical face masks,Jun-20,"Visit the link for more information",https://health.ec.europa.eu/document/download/866b14f5-48f6-48c6-99d9-2e42e475f29a_en?filename=md_guidance-reg-req-med-face-masks.pdf,
MDCG,Helsinki Procedure,Helsinki Procedurefor borderline and classification under MDR & IVDR,"Visit the link for more information",https://health.ec.europa.eu/document/download/2e667094-2eaf-4370-9861-d1a283210da7_en?filename=md_border-class_helsinki-proc-mdr-ivdr_en.pdf,
MDCG,How to verify that medical devices and personal protective equipment can be lawfully placed on the EU market and thus purchased and used – also in the COVID-19 context,May-20,"Visit the link for more information",https://health.ec.europa.eu/document/download/93f64867-996c-468a-b684-e08caad90a53_en?filename=md_mdcg_qa_conformity_documents_en.pdf,
MDCG,Infographic,Is yoursoftwarea Medical Device?,"Visit the link for more information",https://health.ec.europa.eu/document/download/b865d8e9-081a-4601-a91a-f120321c0491_en?filename=md_mdcg_2021_mdsw_en.pdf,
MDCG,MDCG 2018-1 rev. 4,Guidance onbasic UDI-DI and changes to UDI-DI,"Visit the link for more information",https://health.ec.europa.eu/document/download/cb1bf6e5-3972-4b3a-82d9-c5946738b2a5_en?filename=md_mdcg_2018-1_guidance_udi-di_en.pdf,
MDCG,MDCG 2018-2,Future EU medical device nomenclature - Description of requirements,"Visit the link for more information",https://health.ec.europa.eu/document/download/653cb5b3-7cba-4041-935b-c4f044569700_en?filename=md_mdcg_2018_2_nomenclature_en.pdf,
MDCG,MDCG 2018-3 rev.1,Guidance onUDI for systems and procedure packs,"Visit the link for more information",https://health.ec.europa.eu/document/download/b8fa4255-e011-4253-8249-88febab343f2_en?filename=md_2018-3-guidance-udi-spp_en.pdf,
MDCG,MDCG 2018-4,Definitions/descriptions and formats of theUDI core elements for systems or procedure packs,"Visit the link for more information",https://health.ec.europa.eu/document/download/f622a4d7-4ac8-44e3-9217-e2793aa7971f_en?filename=md_mdcg_2018_4_udi_core_spp_en.pdf,
MDCG,MDCG 2018-5,UDI assignmentto medical devicesoftware,"Visit the link for more information",https://health.ec.europa.eu/document/download/4b5b2942-aaab-4b78-a188-df111a8d903e_en?filename=md_mdcg_2018_5_software_en.pdf,
MDCG,MDCG 2018-6,Clarifications ofUDI related responsibilitiesin relation toarticle 16,"Visit the link for more information",https://health.ec.europa.eu/document/download/22503f80-6e3e-422a-b9c1-106c87a3b8f8_en?filename=md_mdcg_2018_6_art16_en.pdf,
MDCG,MDCG 2018-7,Provisional considerations regardinglanguage issuesassociated with theUDI database,"Visit the link for more information",https://health.ec.europa.eu/document/download/d51c7231-c9be-41bb-9a7f-fcf329ca0bd4_en?filename=md_mdcg_2018_7_languages_en.pdf,
MDCG,MDCG 2018-8,"Guidance on content of the certificates, voluntary certificate transfers","Visit the link for more information",https://health.ec.europa.eu/document/download/f654593f-d3a1-4d45-9590-948f61f80fd5_en?filename=md_mdcg_2018_8_crf_transfer_en.pdf,
MDCG,MDCG 2019-1,MDCG guiding principles forissuing entities rules on basic UDI-DI,"Visit the link for more information",https://health.ec.europa.eu/document/download/f278d247-0020-411f-82a6-1d116691c410_en?filename=md_mdcg_2019_1_budi_rules_ie_en.pdf,
MDCG,MDCG 2019-10 rev.1,Application of transitional provisions concerning validity of certificates issued in accordance to the directives,"Visit the link for more information",https://health.ec.europa.eu/document/download/6184a8ab-5d00-45ef-a2b3-3aa266ba5a94_en?filename=md_application-transitional-provisions-certificates_en.pdf,
MDCG,MDCG 2019-11,Qualification and classification of software- Regulation (EU) 2017/745 and Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/b45335c5-1679-4c71-a91c-fc7a4d37f12b_en?filename=md_mdcg_2019_11_guidance_qualification_classification_software_en.pdf,
MDCG,MDCG 2019-12,Designating authority's final assessment form: Key information (EN),"Visit the link for more information",https://health.ec.europa.eu/document/download/b934f2bd-e01f-443e-8bb8-87b5291a892e_en?filename=md_mdcg_key_information_form_en.docx,
MDCG,MDCG 2019-13,Guidance on sampling of devices for the assessment of the technical documentation,"Visit the link for more information",https://health.ec.europa.eu/document/download/36268741-3591-4130-ad21-b09487ff2074_en?filename=md_mdcg_2019_13_sampling_mdr_ivdr_en.pdf,
MDCG,MDCG 2019-14,Explanatory note on MDR codes,"Visit the link for more information",https://health.ec.europa.eu/document/download/6d75a830-9b9b-4e4a-a3b6-047329e9a104_en?filename=md_mdcg_2019_14_mdr_codes_en.pdf,
MDCG,MDCG 2019-15 rev.1,Guidance notes formanufacturers of class Imedical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/349a2d4c-ea2a-4279-861c-7c063bc077e4_en?filename=md_guidance-manufacturers_en.pdf,
MDCG,MDCG 2019-16 rev.1,Guidance on cybersecurity for medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/b23b362f-8a56-434c-922a-5b3ca4d0a7a1_en?filename=md_cybersecurity_en.pdf,
MDCG,MDCG 2019-2,"Guidance on application ofUDI rules to device-part of productsreferred to in article 1(8), 1(9) and 1(10) of Regulation 745/2017","Visit the link for more information",https://health.ec.europa.eu/document/download/12d1f9bd-afe3-42ea-b1a3-20b4986bb3d4_en?filename=md_mdcg_2019_2_gui_udi_dev_en.pdf,
MDCG,MDCG 2019-3 rev.1,Clinical evaluation consultation procedure exemptionsInterpretation of article 54(2)b,"Visit the link for more information",https://health.ec.europa.eu/document/download/c66ca211-7390-4d60-90fc-0fc30652f3db_en?filename=md_mdcg_2019_3_rev1_cecp_en.pdf,
MDCG,MDCG 2019-4,Timelines for registration of devicedata elements in EUDAMED,"Visit the link for more information",https://health.ec.europa.eu/document/download/f13b3ffb-3137-4f5e-bf8f-842ed9ad802e_en?filename=md_mdcg_2019_4_devices_registration_eudamed_en.pdf,
MDCG,MDCG 2019-5,Registration of legacy devicesin EUDAMED,"Visit the link for more information",https://health.ec.europa.eu/document/download/02549ec6-9fe0-484d-a98f-afafdeb51417_en?filename=md_mdcg_2019_5_legacy_devices_registration_eudamed_en.pdf,
MDCG,MDCG 2019-6 rev.4,Questions and answers:Requirements relating to notified bodies,"Visit the link for more information",https://health.ec.europa.eu/document/download/9c9c532f-013a-477c-9378-0a9e714e5549_en?filename=md_mdcg_qa_requirements_notified_bodies_en.pdf,
MDCG,MDCG 2019-7-rev.1,Guidance on article 15 of the medical device regulation (MDR) and in vitro diagnostic device regulation (IVDR) on a ‘person responsible for regulatory compliance’ (PRRC),"Visit the link for more information",https://health.ec.europa.eu/document/download/463b4f08-44a2-4018-9957-488bf386fc3a_en?filename=md_mdcg_2019_7_guidance_art15_mdr_ivdr_en.pdf,
MDCG,MDCG 2019-8 v2,Guidance documentimplant cardon the application of Article 18 Regulation (EU) 2017/745 on medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/e86b9fc4-9785-4c1a-934d-ba11085ff6aa_en?filename=md_mdcg_2019_8_implant_guidance_card_en.pdf,
MDCG,MDCG 2019-9-rev.1,Summary of safety and clinical performance,"Visit the link for more information",https://health.ec.europa.eu/document/download/5f082b2f-8d51-495c-9ab9-985a9f39ece4_en?filename=md_mdcg_2019_9_sscp_en.pdf,
MDCG,MDCG 2020-1,Guidance onclinical evaluation(MDR) /Performance evaluation(IVDR) of medical device software,"Visit the link for more information",https://health.ec.europa.eu/document/download/19d9e24f-2808-4e00-bfeb-75892047407d_en?filename=md_mdcg_2020_1_guidance_clinic_eva_md_software_en.pdf,
MDCG,MDCG 2020-10/1 rev.1,Guidance onsafety reportingin clinical investigationsAppendix: Clinical investigation summary safety report form,"Visit the link for more information",https://health.ec.europa.eu/document/download/0537d335-7eed-4087-b65d-3c2bd8c72c1a_en?filename=md_mdcg_2020-10-1_guidance_safety_reporting_en.pdf,
MDCG,MDCG 2020-11,Guidance on the renewal of designation and monitoring of notified bodies under Directives 90/385/EEC and 93/42/EEC to be performed in accordance with Commission Implementing Regulation (EU) 2020/666 amending Commission Implementing Regulation (EU) 920/2013,"Visit the link for more information",https://health.ec.europa.eu/document/download/e0c2afff-bce5-44b1-8318-40c40503772a_en?filename=md_mdcg_2020-11_guidance_renewal_designation_en.pdf,
MDCG,MDCG 2020-12,"Guidance on transitional provisions for consultations of authorities on devices incorporating a substance which may be considered a medicinal product and which has action ancillary to that of the device, as well as on devices manufactured using TSE susceptible animal tissues","Visit the link for more information",https://health.ec.europa.eu/document/download/ced09394-5757-4eb0-9700-7442959e6c54_en?filename=md_mdcg_2020-12_guidance_transitional_provisions_en.pdf,
MDCG,MDCG 2020-13,Clinical evaluation assessment report template,"Visit the link for more information",https://health.ec.europa.eu/document/download/02f50abc-91db-4ad9-b137-6ffedb690716_en?filename=md_2020-13-cea-report-template_en.pdf,
MDCG,MDCG 2020-14,Guidance for notified bodies on the use of MDSAP audit reports in the context of surveillance audits carried out under the Medical Devices Regulation (MDR)/In Vitro Diagnostic medical devices Regulation (IVDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/44dc96aa-e517-4af1-855b-f7fcb4b699c9_en?filename=md_2020-14-guidance-mdsap_en.pdf,
MDCG,MDCG 2020-15,MDCG Position Paper on theuse of the EUDAMED actor registration moduleand of the Single Registration Number (SRN) in the Member States,"Visit the link for more information",https://health.ec.europa.eu/document/download/82e23e4e-5b00-4520-b3a5-18f58df22e6e_en?filename=2020-15-position-paper-actor-registration-module_en.pdf,
MDCG,MDCG 2020-16 rev.3,Guidance onClassification Rulesfor in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/12f9756a-1e0d-4aed-9783-d948553f1705_en?filename=md_mdcg_2020_guidance_classification_ivd-md_en.pdf,
MDCG,MDCG 2020-17,Questions and Answers related to MDCG 2020-4:“Guidance on temporary extraordinary measures related to medical device notified bodyaudits during COVID-19quarantine orders and travel restrictions”,"Visit the link for more information",https://health.ec.europa.eu/document/download/a3bbc84b-078a-46d7-a281-d68136da6d38_en?filename=md_2020-17-guidance-mdcg-qa_en.pdf,
MDCG,MDCG 2020-18,MDCG Position Paper onUDI assignment for Spectacle lenses & Ready readers,"Visit the link for more information",https://health.ec.europa.eu/document/download/50a619f7-749c-4457-8931-786f1012588c_en?filename=md_mdcg_2020_18_en.pdf,
MDCG,MDCG 2020-2 rev.1,Class I transitional provisionsunder Article 120 (3 and 4) – (MDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/e87d08dc-87ab-49d9-8ffa-5552fa978d14_en?filename=md_transitional-provisions-art-3-and-4_en.pdf,
MDCG,MDCG 2020-3 rev.1,"Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDDNote to the reader: Due to technical issues, please disregard the document displayed from 7 September 2023 until 8 September 2023.","Visit the link for more information",https://health.ec.europa.eu/document/download/800e8e87-d4eb-4cc5-b5ad-07a9146d7c90_en?filename=mdcg_2020-3_en_1.pdf,
MDCG,MDCG 2020-4,Guidance on temporary extraordinary measures related to medical device notified body audits during COVID-19 quarantine orders and travel restrictions,"Visit the link for more information",https://health.ec.europa.eu/document/download/8811a216-fdd1-45c7-bd82-381a37696f05_en?filename=md_mdcg_2020_4_nb_audits_covid-19_en.pdf,
MDCG,MDCG 2020-5,Guidance onclinical evaluation – Equivalence,"Visit the link for more information",https://health.ec.europa.eu/document/download/575a0f79-e3a0-4a96-9ce0-930576c12aa2_en?filename=md_mdcg_2020_5_guidance_clinical_evaluation_equivalence_en.pdf,
MDCG,MDCG 2020-6,Guidance on sufficientclinical evidence for legacy devicesBackground noteon the relationship between MDCG 2020-6 and MEDDEV 2.7/1 rev.4 on clinical evaluation,"Visit the link for more information",https://health.ec.europa.eu/document/download/a6d29444-b5d5-4afb-8024-10be85256aa7_en?filename=md_mdcg_2020_6_guidance_sufficient_clinical_evidence_en.pdf,
MDCG,MDCG 2020-7,Guidance onPMCF plantemplate,"Visit the link for more information",https://health.ec.europa.eu/document/download/a5cdb303-c782-4010-8723-7d389af678f7_en?filename=md_mdcg_2020_7_guidance_pmcf_plan_template_en.pdf,
MDCG,MDCG 2020-8,Guidance onPMCF evaluation reporttemplate,"Visit the link for more information",https://health.ec.europa.eu/document/download/11121036-696a-4589-a311-c5525bd84df3_en?filename=md_mdcg_2020_8_guidance_pmcf_evaluation_report_en.pdf,
MDCG,MDCG 2020-9,Regulatory requirements forventilators and related accessories,"Visit the link for more information",https://health.ec.europa.eu/document/download/801d2a91-7c99-4710-9302-c0fbcc60f6f6_en?filename=md_mdcg_2020-9_regulatory_requirements_ventilators_en.pdf,
MDCG,MDCG 2021-09,"MDCG Position Paper on the Implementation ofUDI requirements for contact lenses, spectacle frames, spectacle lenses & ready readers","Visit the link for more information",https://health.ec.europa.eu/document/download/3f68dcc3-b9a6-428a-b2ce-713ee986a0ba_en?filename=md_2021-9_en.pdf,
MDCG,MDCG 2021-1 Rev. 1,Guidance on harmonised administrative practices andalternativetechnicalsolutions until EUDAMED is fully functional,"Visit the link for more information",https://health.ec.europa.eu/document/download/ea0369a7-d86c-465e-9a54-0c0dfb01bc84_en?filename=2021-1_guidance-administrative-practices_en.pdf,
MDCG,MDCG 2021-10,The status of AppendixesE-I of IMDRF N48under the EU regulatory framework for medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/85f65be1-9a43-44b6-8cdd-779ca16bc843_en?filename=md_2021-10_en.pdf,
MDCG,MDCG 2021-11,Guidance onImplant Card – Device types,"Visit the link for more information",https://health.ec.europa.eu/document/download/498f68ec-ce00-425d-a722-69ac2be6c1b9_en?filename=md_2021-11_en.pdf,
MDCG,MDCG 2021-12 rev.1,FAQ on the European Medical Device Nomenclature (EMDN),"Visit the link for more information",https://health.ec.europa.eu/document/download/d90b3f63-1d62-43e6-bf5f-fb32ea7c47a2_en?filename=md_2021-12_en.pdf,
MDCG,MDCG 2021-13 Rev. 1,"Questions and answerson obligations and related rules for theregistrationin EUDAMEDof actors other thanmanufacturers, authorised representatives and importers subject to the obligations ofArticle 31 MDR and Article 28 IVDR","Visit the link for more information",https://health.ec.europa.eu/document/download/8e9adf30-71b5-4faf-a8fb-b35ce4804440_en?filename=md_mdcg_2021-13_q-a-actor_registr_eudamed_en.pdf,
MDCG,MDCG 2021-14,Explanatory note onIVDR codes,"Visit the link for more information",https://health.ec.europa.eu/document/download/94b7e87c-ce5f-49b9-82a4-9eec6b0591bb_en?filename=md_mdcg_2021-14-guidance-ivdr-codes_en.pdf,
MDCG,MDCG 2021-15,Application formto be submitted by a conformity assessment body when applying fordesignation as notified bodyunder the medical devices regulation (MDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/f1202a34-d27b-40f4-a777-975fc78dab47_en?filename=mdcg_2021-15_en.docx,
MDCG,MDCG 2021-15/MDCG 2024-7 Annex,Annex to Application Form & PAR Template MDR (List of documents),"Visit the link for more information",https://health.ec.europa.eu/document/download/ec243aca-cca6-4b38-bf3b-ce22396ccc0f_en?filename=mdcg_2021-15_and_2024-7_annex_en.docx, 
MDCG,MDCG 2021-16,Application formto be submitted by a conformity assessment body when applying fordesignation as notified bodyunder the in vitro diagnostic devices regulation (IVDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/2b39d49f-4158-4470-b051-268cea9f21e1_en?filename=mdcg_2021-16_en.docx,
MDCG,MDCG 2021-17,Applied-for scope ofdesignation and notification of a conformity assessment body– Regulation (EU) 2017/745 (MDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/d0fe229f-c9e3-4f75-bf3b-bc4381206eef_en?filename=mdcg_2021-17_en.docx,
MDCG,MDCG 2021-18,Applied-for scope ofdesignation and notification of a conformity assessment body– Regulation (EU) 2017/746 (IVDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/79150afd-7758-4023-978b-ec726f760482_en?filename=mdcg_2021-18_en.docx,
MDCG,MDCG 2021-19,Guidance note integration of theUDIwithin an organisation’squality management system,"Visit the link for more information",https://health.ec.europa.eu/document/download/64443e95-e1be-4ffd-80f7-9c6a1b0b99b6_en?filename=md_2021-19_en.pdf,
MDCG,MDCG 2021-2,Guidance on state of the art ofCOVID-19 rapid antibody tests,"Visit the link for more information",https://health.ec.europa.eu/document/download/3564ab86-8773-4499-8011-58beb77e80af_en?filename=mdcg_2021-2_en.pdf,
MDCG,MDCG 2021-20,Instructions forgenerating CIV-IDfor MDR Clinical Investigations,"Visit the link for more information",https://health.ec.europa.eu/document/download/54d417c4-df69-416f-a2bd-7a5de8cba611_en?filename=mdcg_2021-20_en.pdf,
MDCG,MDCG 2021-21 rev.1,Guidance onperformance evaluation of SARS-CoV-2in vitro diagnostic medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/729f09dc-9f95-40b9-a62a-a0e9fff1d252_en?filename=mdcg_2021-21_en.pdf,
MDCG,MDCG 2021-22 rev.1,"Clarification on “first certification for that type of device” and corresponding procedures to be followed by notified bodies, in context of theconsultation of the expert panelreferred to in Article 48(6) of Regulation (EU) 2017/746","Visit the link for more information",https://health.ec.europa.eu/document/download/98db0ec5-306f-4a0d-8bc9-5724f5d48942_en?filename=mdcg_2021-22_en.pdf,
MDCG,MDCG 2021-23,"Guidance for notified bodies, distributors and importers oncertification activitiesin accordance with Article 16(4) of Regulation (EU) 2017/745 and Regulation (EU) 2017/746","Visit the link for more information",https://health.ec.europa.eu/document/download/e985ea01-e6b7-4900-af3a-58e5b01678aa_en?filename=mdcg_2021-23_en.pdf,
MDCG,MDCG 2021-24,Guidance onclassificationof medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf,
MDCG,MDCG 2021-25,"Application of MDR requirements to ""legacy devices"" and to devices placed on the market prior to 26 May 2021 in accordance with Directives 90/385/EEC or 93/42/EEC","Visit the link for more information",https://health.ec.europa.eu/document/download/cbb11a6e-f0f3-4e30-af5e-990f9ef68bc1_en?filename=md_mdcg_2021_25_en.pdf,
MDCG,MDCG 2021-25 Rev. 1,"MDCG 2021-25 rev.1 - Application of MDR requirements to ""legacy devices"" and to devices placed on the market prior to 26 May 2021 - October 2024","Visit the link for more information",https://health.ec.europa.eu/document/download/cbb11a6e-f0f3-4e30-af5e-990f9ef68bc1_en?filename=md_mdcg_2021_25_en.pdf,
MDCG,MDCG 2021-26,Q&A onrepackaging & relabellingactivities under Article 16 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/4c7bd740-d7c3-4f7b-9a4d-249121a67b8a_en?filename=md_mdcg_2021_26_en.pdf,
MDCG,MDCG 2021-27-rev.1,Questions and Answers on Articles 13 & 14 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/82d9adbc-dbf0-40d4-93ed-ade673c8232a_en?filename=mdcg_2021-27_en.pdf,
MDCG,MDCG 2021-28,Substantial modificationof clinical investigation under Medical Device Regulation,"Visit the link for more information",https://health.ec.europa.eu/document/download/ba8069a1-6881-4360-b52b-6cab048aee43_en?filename=mdcg_2021-28_en.pdf,
MDCG,MDCG 2021-3,Questions and Answerson Custom-Made Devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/385d7e20-d8b5-49d0-abd7-8daf269bf1b8_en?filename=mdcg_2021-3_en.pdf,
MDCG,MDCG 2021-4 rev.1,Application oftransitional provisionsfor certification ofclass Din vitro diagnostic medical devices according to Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/9f23fca0-f407-4e45-a464-2d71b575d1fe_en?filename=mdcg_2021-4_en.pdf,
MDCG,MDCG 2021-5 Rev.1,Guidance onstandardisation for medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/59ac4cb0-f187-4ca2-814d-82c42cde5408_en?filename=md_mdcg_2021_5_en.pdf,
MDCG,MDCG 2021-6-rev.1,Regulation (EU) 2017/745 –Questions & Answersregardingclinical investigation,"Visit the link for more information",https://health.ec.europa.eu/document/download/f124f630-389e-4c45-90dc-24ec0a707838_en?filename=mdcg_2021-6_en.pdf,
MDCG,MDCG 2021-7,Notice to manufacturers and authorised representatives on theimpact of genetic variants on SARS-COV-2in vitro diagnostic medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/35a97144-cb8b-4067-b81a-dac6e13a92e8_en?filename=mdcg_2021-7_en.pdf,
MDCG,MDCG 2021-8,Clinical investigationapplication/notification documents,"Visit the link for more information",https://health.ec.europa.eu/document/download/13265ec7-1776-41af-afb6-e0a64bc407b5_en?filename=mdcg_2021-8_en.pdf,
MDCG,MDCG 2022-1,Notice to 3rd country manufacturersof SARS-CoV-2 in vitro diagnostic medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/cd617093-f2bd-4a99-9058-9805ce4d0db3_en?filename=mdcg_2022-1_en.pdf,
MDCG,MDCG 2022-10,Q&A on the interface between Regulation (EU) 536/2014 on clinical trials for medicinal products for human use (CTR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/59abcc81-fd32-4546-a340-24c8fad4e2ac_en?filename=mdcg_2022-10_en.pdf,
MDCG,MDCG 2022-11-rev.1,MDCG Position Paper: Notice to manufacturers to ensure timely compliance with MDR and IVDR requirements,"Visit the link for more information",https://health.ec.europa.eu/document/download/5ec4d600-d344-4232-9371-1d278b2abc12_en?filename=mdcg_2022-11_en.pdf,
MDCG,MDCG 2022-12,Guidance on harmonised administrative practices and alternative technical solutions until Eudamed is fully functional (for Regulation (EU) 2017/746 on in vitro diagnostic medical devices),"Visit the link for more information",https://health.ec.europa.eu/document/download/c9008091-8ad7-4449-af75-f4f5a6abc761_en?filename=md_mdcg_2022-12_guidance-admpractice_techsol_eudamed_en_0.pdf,
MDCG,MDCG 2022-13 rev.1,"Designation, re-assessment and notification of conformity assessment bodies and notified bodies","Visit the link for more information",https://health.ec.europa.eu/document/download/27f91dc2-b5bc-44f9-a975-5024ce3ea556_en?filename=mdcg_2022-13_en.pdf,
MDCG,MDCG 2022-14,Transition to the MDR and IVDR - Notified body capacity and availability of medical devices and IVDs,"Visit the link for more information",https://health.ec.europa.eu/document/download/2db053bc-283c-4d2e-93f4-c3e8032e66da_en?filename=mdcg_2022-14_en.pdf,
MDCG,MDCG 2022-15,Guidance on appropriate surveillance regarding the transitional provisions under Article 110 of the IVDR with regard to devices covered by certificates according to the IVDD,"Visit the link for more information",https://health.ec.europa.eu/document/download/9518a759-24ce-4e15-83a5-e7b383911000_en?filename=mdcg_2022-15_en.pdf,
MDCG,MDCG 2022-16,Guidance on Authorised Representatives Regulation (EU) 2017/745 and Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/0a7613cb-6b9a-4396-a4c6-d2479e43e167_en?filename=mdcg_202216_en.pdf,
MDCG,MDCG 2022-17,"MDCG position paper on ""hybrid audits","Visit the link for more information",https://health.ec.europa.eu/document/download/c2b875dd-06dd-47b6-8822-afe43f630655_en?filename=mdcg_2022-17_en_0.pdf,
MDCG,MDCG 2022-18,MDCG Position Paper on the application of Article 97 MDR to legacy devices for which the MDD or AIMDD certificate expires before the issuance of a MDR certificate,"Visit the link for more information",https://health.ec.europa.eu/document/download/ccfb20a8-82d4-4216-8d11-4ce127be431e_en?filename=mdcg_2022-18_en_1.pdf,
MDCG,MDCG 2022-18 ADD.1,MDCG Position Paper on the application of Article 97 MDR to legacy devices for which the MDD or AIMDD certificate expires before the issuance of a MDR certificate - Addendum 1,"Visit the link for more information",https://health.ec.europa.eu/document/download/8c49c181-1f8a-4962-b946-7b02c54b199e_en?filename=mdcg_2022-18_add-1_en.pdf,
MDCG,MDCG 2022-19,Performance study application/notification documents under Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/4e1f946d-a71a-42c7-bd98-0e9977752669_en?filename=mdcg_2022-19_en.pdf,
MDCG,MDCG 2022-2,Guidance on general principles ofclinical evidencefor In Vitro Diagnostic medical devices (IVDs),"Visit the link for more information",https://health.ec.europa.eu/document/download/f373538f-939c-472f-9536-436b6ddac085_en?filename=mdcg_2022-2_en.pdf,
MDCG,MDCG 2022-20,Substantial modification of performance study under Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/6a354f46-8308-4d60-a36d-2ef1ba56e41a_en?filename=mdcg_2022-20_en.pdf,
MDCG,MDCG 2022-21,Guidance on Periodic Safety Update Report (PSUR) according to Regulation (EU) 2017/745,"Visit the link for more information",https://health.ec.europa.eu/document/download/a7df24c3-d4a3-4218-a8e0-726febfa01c2_en?filename=mdcg_2022-21_en.pdf,
MDCG,MDCG 2022-3,Verification of manufactured class D IVDs by notified bodies,"Visit the link for more information",https://health.ec.europa.eu/document/download/ebbc4f6a-4945-4d5d-9c22-9bc1aafc5532_en?filename=mdcg_2022-3_en.pdf,
MDCG,MDCG 2022-4 rev.2,Guidance on appropriate surveillance regarding the transitional provisions under Article 120 of the MDR with regard to devices covered by certificates according to the MDD or the AIMDD,"Visit the link for more information",https://health.ec.europa.eu/document/download/e5714b2b-e98b-4fce-b5ff-d9141a8f30e1_en?filename=mdcg_2022-4_en.pdf,
MDCG,MDCG 2022-5 Rev. 1,Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/b5a27717-229f-4d7a-97b1-e1c7d819e579_en?filename=mdcg_2022-5_en.pdf,
MDCG,MDCG 2022-6,Guidance on significant changes regarding the transitional provision under Article 110(3) of the IVDR,"Visit the link for more information",https://health.ec.europa.eu/document/download/14c2d8dd-8489-4db5-b035-1c174f17fb54_en?filename=mdcg_2022-6.pdf,
MDCG,MDCG 2022-7,Q&A on the Unique Device Identification system under Regulation (EU) 2017/745 and Regulation (EU),"Visit the link for more information",https://health.ec.europa.eu/document/download/b5429d14-25a9-4cfc-b059-355388f03e05_en?filename=mdcg_2022-7_en.pdf,
MDCG,MDCG 2022-8,Regulation (EU) 2017/746 - application of IVDR requirements to ‘legacy devices’ and to devices placed on the market prior to 26 May 2022 in accordance with Directive 98/79/EC,"Visit the link for more information",https://health.ec.europa.eu/document/download/76f9983e-164c-45f1-b2b9-c9e5050cefe9_en?filename=mdcg_2022-8_en.pdf,
MDCG,MDCG 2022-9 rev.1,Summary of safety and performance template,"Visit the link for more information",https://health.ec.europa.eu/document/download/b7cf356f-733f-4dce-9800-0933ff73622a_en?filename=mdcg_2022-9_en.pdf,
MDCG,MDCG 2023-1,Guidance on the health institution exemption under Article 5(5) of Regulation (EU) 2017/745 and Regulation (EU) 2017/746,"Visit the link for more information",https://health.ec.europa.eu/document/download/05b15d55-1bcf-4e17-99c4-15c706325847_en?filename=mdcg_2023-1_en.pdf,
MDCG,MDCG 2023-2,List of Standard Fees,"Visit the link for more information",https://health.ec.europa.eu/document/download/309b49d8-07dd-40bf-b3a1-649dbdc378af_en?filename=mdcg_2023-2_en.pdf,
MDCG,MDCG 2023-3,Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/af1433fd-ed64-4c53-abc7-612a7f16f976_en?filename=mdcg_2023-3_en_0.pdf,
MDCG,MDCG 2023-4,Medical Device Software (MDSW) – Hardware combinations Guidance on MDSW intended to work in combination with hardware or hardware components,"Visit the link for more information",https://health.ec.europa.eu/document/download/b2c4e715-f2b4-4d24-af60-056b5d41a72e_en?filename=md_mdcg_2023-4_software_en.pdf,
MDCG,MDCG 2023-5,Guidance on qualification and classification of Annex XVI products - A guide for manufacturers and notified bodies,"Visit the link for more information",https://health.ec.europa.eu/document/download/ea4acf26-979a-4dbb-92ff-8d1d804da51a_en?filename=mdcg_2023-5_en.pdf,
MDCG,MDCG 2023-6,Guidance on demonstration of equivalence for Annex XVI products - A guide for manufacturers and notified bodies,"Visit the link for more information",https://health.ec.europa.eu/document/download/15a33521-87f1-4939-92a1-ef23f2b09c6c_en?filename=mdcg_2023-6_en.pdf,
MDCG,MDCG 2023-7,Guidance on exemptions from the requirement to perform clinical investigations pursuant to Article 61(4)-(6) MDR and on sufficient levels of access’ to data needed to justify claims of equivalence,"Visit the link for more information",https://health.ec.europa.eu/document/download/1b5f9cc0-cea0-4459-921f-eaf4b4f80983_en?filename=mdcg_2023-7_en.pdf,
MDCG,MDCG 2024-1,Device Specific Vigilance Guidance (DSVG) Template,"Visit the link for more information",https://health.ec.europa.eu/document/download/dbd0d748-d646-4274-afaa-399952809389_en?filename=mdcg_2024-1_en.pdf,
MDCG,MDCG 2024-10,Clinical evaluation of orphan medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/daa1fc59-9d2c-4e82-878e-d6fdf12ecd1a_en?filename=mdcg_2024-10_en.pdf,
MDCG,MDCG 2024-11,Guidance on qualification of in vitro diagnostic medical devices,"Visit the link for more information",https://health.ec.europa.eu/document/download/12b92152-371f-404d-a865-93800cd5cdca_en?filename=mdcg_2024-11_en.pdf,
MDCG,MDCG 2024-1-1,DSVG 01 on Cardiac ablation,"Visit the link for more information",https://health.ec.europa.eu/document/download/e170bdf5-1684-4e24-bfbc-ec34b1ea1b4f_en?filename=mdcg_2024-1-1_en.pdf,
MDCG,MDCG 2024-12,"Corrective and preventive action (CAPA) plan assessment: guidance and templates for conformity assessment bodies, notified bodies, designating authorities, and joint assessment teamsAnnex I: Template CAPA plan and assessment thereonAnnex II: Template JAT review of the CAPA and the DA's opinion","Visit the link for more information",https://health.ec.europa.eu/document/download/080c6aed-4f09-4a8a-b052-3414275945db_en?filename=mdcg_2024-12_en.pdf,
MDCG,MDCG 2024-1-2,DSVG 02 on Coronary stents,"Visit the link for more information",https://health.ec.europa.eu/document/download/6bfe418c-b72e-4e8a-b7e3-7aa1d0060da8_en?filename=mdcg_2024-1-2_en.pdf,
MDCG,MDCG 2024-13,MDCG 2024-13 - Regulatory status of ethylene oxide (EtO) intended for the sterilisation of medical devices - October 2024,"Visit the link for more information",https://health.ec.europa.eu/document/download/3fa74c6b-953a-41f5-b024-8889ac8b5ddf_en?filename=mdcg_2024-13_en.pdf,
MDCG,MDCG 2024-1-3,DSVG 03 on Cardiac implantable electronic devices (CIEDs),"Visit the link for more information",https://health.ec.europa.eu/document/download/c1e34b32-4faf-4ea5-af66-959642148b3a_en?filename=mdcg_2024-1-3_en.pdf,
MDCG,MDCG 2024-14,"MDCG 2024-14 Guidance on the implementation of 
the Master UDI-DI solution for 
contact lenses ","This document aims to provide guidance in the implementation of Master UDI-DI rules for 
contact lenses as regards its structure, assignment, labelling and registration in Eudamed.",https://health.ec.europa.eu/document/download/c8c6cca5-460e-410e-a325-be08bfc7dea6_en?filename=mdcg_2024-14_en.pdf,
MDCG,MDCG 2024-1-4,DSVG 04 on Breast implants,"Visit the link for more information",https://health.ec.europa.eu/document/download/07c958e3-c2c7-4a22-82f1-86ab2debf40e_en?filename=mdcg_2024-1-4_en.pdf,
MDCG,MDCG 2024-1-5,DSVG 05 on Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence,"Visit the link for more information",https://health.ec.europa.eu/document/download/c8441ddc-c586-4dbf-afc8-6ec3250df54b_en?filename=mdcg_2024-1-5_en_1.pdf,
MDCG,MDCG 2024-2 rev.1,Procedures for the updates of the EMDN,"Visit the link for more information",https://health.ec.europa.eu/document/download/de470384-e8be-45e7-a334-226757f8816d_en?filename=mdcg_2024-2_en.pdf,
MDCG,MDCG 2024-3,Guidance on content of the Clinical Investigation Plan for clinical investigations of medical devicesClinical Investigation Plan Synopsis Template,"Visit the link for more information",https://health.ec.europa.eu/document/download/690de85a-ac17-45ea-bb32-7839540c25c4_en?filename=mdcg_2024-3_en_0.pdf,
MDCG,MDCG 2024-4,Safety reporting in performance studies of in vitro diagnostic medical devices under Regulation (EU) 2017/746Appendix – Performance Study Summary Safety Reporting Form,"Visit the link for more information",https://health.ec.europa.eu/document/download/5cc894e0-331d-4fa2-8ab3-cdd4437c48fc_en?filename=mdcg_2024-4_en.pdf,
MDCG,MDCG 2024-5,Guidance on the Investigator’s Brochure contentAppendix A of the MDCG 2024-5,"Visit the link for more information",https://health.ec.europa.eu/document/download/ee7ee8eb-841a-4085-a8dc-af6d55ebf1bd_en?filename=mdcg_2024-5_en.pdf,
MDCG,MDCG 2024-6,Preliminary re-assessment review (PRAR) form template (MDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/88772d4f-9e29-4b1b-aa41-adcc74b6bb41_en?filename=mdcg_2024-6_en_0.docx,
MDCG,MDCG 2024-7,Preliminary assessment review template – MDR (Regulation (EU) 2017/745) Revision 1,"Visit the link for more information",https://health.ec.europa.eu/document/download/939cc0b8-8db5-4b0d-b2b7-a15a98a44cbd_en?filename=mdcg_2024-7_en_0.docx,
MDCG,MDCG 2024-7 Annex,Annex to Application Form & PAR Template MDR (List of documents),"Visit the link for more information",https://health.ec.europa.eu/document/download/ec243aca-cca6-4b38-bf3b-ce22396ccc0f_en?filename=mdcg_2021-15_and_2024-7_annex_en.docx, 
MDCG,MDCG 2024-8,Preliminary assessment review (PAR) form template (IVDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/9819fd07-3281-477b-a8c6-22c0c47c47a6_en?filename=mdcg_2024-8_en_0.docx,
MDCG,MDCG 2021-16/MDCG 2024-8 Annex,Annex to Application Form & PAR Template IVDR (List of documents),"Visit the link for more information",https://health.ec.europa.eu/document/download/14dd6ea0-3572-4056-984f-911e9a87fae8_en?filename=mdcg_2021-16_and_2024-8_annex_en.docx,  
MDCG,MDCG 2024-9,Preliminary re-assessment review (PRAR) form template (IVDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/f067a42e-4af6-47dd-980f-b251eeeafaf0_en?filename=mdcg_2024-9_en_0.docx,
MDCG,MDR/IVDR Language requirements,Overview of language requirements for manufacturers of medical devices for the information and instructions that accompany a device in a specific country,"Visit the link for more information",https://health.ec.europa.eu/publications/overview-language-requirements-manufacturers-medical-devices_en,
MDCG,NBOG BPG 2017-2,Best practice guidance on the information required for personnel involved in conformity assessment,"Visit the link for more information",https://health.ec.europa.eu/document/download/9208332f-7b02-43c7-99d8-193d705a6dff_en?filename=md_mdcg_2017_2_nbog_bpg_en.pdf,
MDCG,NBOG F 2017-7,Review of qualification for the authorisation of personnel (MDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/d7183af8-a1ef-4f5d-b351-41a34f1a2049_en?filename=md_mdcg_2017_7_nbog_mdr_en.doc,
MDCG,NBOG F 2017-8,Review of qualification for the authorisation of personnel (IVDR),"Visit the link for more information",https://health.ec.europa.eu/document/download/28cff0d2-72c7-48d0-83fb-8e698dc51671_en?filename=md_mdcg_2017_8_nbog_mdr_en.doc,
MDCG,Q&A,"Q&A on practical aspects related to the implementation of the extended transitional period provided for in the IVDR, as amended by Regulation (EU) 2024/1860","Visit the link for more information",https://health.ec.europa.eu/document/download/dfd7a1c6-f319-4682-9bac-77bef1165818_en?filename=mdr_qna-ext-ivdr.pdf,
MDCG,Q&A Rev. 2,Q&A on practical aspects related to the implementation of Regulation (EU) 2023/607 - Extension of the MDR transitional period and removal of the “sell off” periods,"Visit the link for more information",https://health.ec.europa.eu/document/download/592008f6-3456-4afb-a13a-733a87da1b00_en?filename=mdr_proposal_extension-q-n-a_1.pdf,
MDCG,SCHEER guidelines,"Update on the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devicescovering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties","Visit the link for more information",https://health.ec.europa.eu/document/download/831f9b60-88de-4197-858f-d001c5b0cc26_en?filename=mdcg_scheer_o_064.pdf,
MDCG,The CND nomenclature – Background and general principles,Jan-20,"Visit the link for more information",https://health.ec.europa.eu/document/download/69373ce1-3248-4431-be50-b2d430e61951_en?filename=md_cnd_general_principles_en.pdf,
MDCG,The EMDN – The nomenclature of use in EUDAMED,Jan-20,"Visit the link for more information",https://health.ec.europa.eu/document/download/95d6ae6c-6a1e-4b76-ac8d-46475f8c5f1a_en?filename=md_emdn_eudamed_nomenclature_en.pdf,
